Grupo SBF S.A (SBFG3)
B3 Stock Exchange · Brazil · prices in BRL · close of 23 Oct 2026
Key indicators
| Last close | BRL 11.36 |
|---|---|
| 52-week range | 7.50 – 16.00 |
| Return, 1 month / 3 months | +34.6% / +18.7% |
| Return, 1 year / 3 years | −4.6% / +78.5% |
| Trend | Uptrend |
| RSI (14) | 66 |
| Volatility (1 year) | 51.0% |
| Worst drawdown (1 year) | -48.9% |
| Average daily value traded | 32.54M BRL |
| Dividend yield | 4.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Grupo SBF is a Brazilian retailer of sporting goods based in Sao Paulo. It runs the Centauro chain of sports stores, offering footwear, apparel and equipment for activities such as football, running and fitness. The company also operates Nike-branded stores in Brazil under a licensing arrangement, serving everyday consumers and athletes through its physical shops and online channels. Its customers are mainly Brazilian shoppers looking for sportswear and athletic gear.
On this site Grupo SBF S.A appears as a stock on the B3 Stock Exchange (Brazil), code SBFG3, with prices in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Grupo SBF S.A (SBFG3) trades on the B3 Stock Exchange in Brazil. It last closed at BRL 11.36 on 23 October 2026.
Its price-based Market X-Ray is 42 out of 100 (a weak price profile), ranking 965 of 1,455 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 4.6% and over the last three months it rose 18.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on B3 Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 31 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | 6.0% | ||
| From 52-week high | -27.4% | ||
| Momentum | 41 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 18.7% | ||
| 6-month return | -3.0% | ||
| 12-month return, skipping the last month | -29.1% | ||
| Stability (higher is calmer) | 25 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 51.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -48.9% | ||
| Liquidity | 90 · Strong | Trades actively. | |
| Average daily value traded | 32.54M BRL | ||
| Zero-volume days | 0.0% | ||
| Income | 40 · Weak | Dividend is small or irregular. | |
| Dividend yield | 4.8% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +13.4% |
|---|---|
| 1 month | +34.6% |
| 3 months | +18.7% |
| 6 months | −3.0% |
| 1 year | −4.6% |
| 3 years | +78.5% |
| 5 years | −45.4% |
Signals
| 50-day / 200-day average | 8.87 / 10.71 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.67 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 24 Apr 2026 | BRL 0.5429 |
| 25 Apr 2025 | BRL 0.5484 |
| 26 Apr 2024 | BRL 0.1717 |
| 28 Apr 2023 | BRL 0.1358 |
| 29 Apr 2022 | BRL 0.1179 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on B3 Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.